Shares of Glenmark Pharmaceuticals today rallied over 3 per cent on HSBC rating.
The stock jumped as much as 3.4 per cent as HSBC has upgraded the stock to “buy’’ from “hold’’.
The company has reported below forecast earnings for December quarter.
All negatives are priced in and the stock is trading 20 per cent cheaper to peers, HSBC says.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.